Andrew Mulcahy

1.9k total citations
82 papers, 1.2k citations indexed

About

Andrew Mulcahy is a scholar working on Economics and Econometrics, General Health Professions and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Andrew Mulcahy has authored 82 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Economics and Econometrics, 26 papers in General Health Professions and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Andrew Mulcahy's work include Healthcare Policy and Management (31 papers), Health Systems, Economic Evaluations, Quality of Life (27 papers) and Pharmaceutical Economics and Policy (23 papers). Andrew Mulcahy is often cited by papers focused on Healthcare Policy and Management (31 papers), Health Systems, Economic Evaluations, Quality of Life (27 papers) and Pharmaceutical Economics and Policy (23 papers). Andrew Mulcahy collaborates with scholars based in United States, United Kingdom and Netherlands. Andrew Mulcahy's co-authors include Ateev Mehrotra, Jakub Hlávka, Lori Uscher‐Pines, Gerald Hunter, Rachel Burns, David Cowling, Kenneth Finegold, Patricia M. Danzon, Adrian Towse and Lane F. Burgette and has published in prestigious journals such as New England Journal of Medicine, JAMA and PLoS ONE.

In The Last Decade

Andrew Mulcahy

72 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Mulcahy United States 20 564 377 237 218 126 82 1.2k
Karen Facey United Kingdom 22 894 1.6× 504 1.3× 90 0.4× 215 1.0× 109 0.9× 50 2.2k
Mariângela Leal Cherchiglia Brazil 24 287 0.5× 605 1.6× 96 0.4× 275 1.3× 174 1.4× 147 2.0k
Céu Mateus United Kingdom 22 375 0.7× 465 1.2× 174 0.7× 239 1.1× 543 4.3× 101 2.0k
Adrian Gheorghe United Kingdom 17 332 0.6× 261 0.7× 85 0.4× 173 0.8× 92 0.7× 31 1.3k
Livio Garattini Italy 25 825 1.5× 281 0.7× 116 0.5× 113 0.5× 118 0.9× 133 1.8k
Ewa Orlewska Poland 11 697 1.2× 331 0.9× 118 0.5× 122 0.6× 158 1.3× 51 1.7k
Marthe‐Lisa Schaarschmidt Germany 17 260 0.5× 215 0.6× 426 1.8× 81 0.4× 64 0.5× 45 989
Димитра Пантели Germany 21 547 1.0× 500 1.3× 46 0.2× 279 1.3× 82 0.7× 74 1.3k
Fernando Antoñanzas Spain 23 768 1.4× 377 1.0× 63 0.3× 190 0.9× 112 0.9× 140 2.3k
Kees de Joncheere Switzerland 14 787 1.4× 217 0.6× 91 0.4× 101 0.5× 67 0.5× 23 1.3k

Countries citing papers authored by Andrew Mulcahy

Since Specialization
Citations

This map shows the geographic impact of Andrew Mulcahy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Mulcahy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Mulcahy more than expected).

Fields of papers citing papers by Andrew Mulcahy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Mulcahy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Mulcahy. The network helps show where Andrew Mulcahy may publish in the future.

Co-authorship network of co-authors of Andrew Mulcahy

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Mulcahy. A scholar is included among the top collaborators of Andrew Mulcahy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Mulcahy. Andrew Mulcahy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mulcahy, Andrew, et al.. (2025). Use of Clinical Trial Characteristics to Estimate Costs of New Drug Development. JAMA Network Open. 8(1). e2453275–e2453275. 5 indexed citations
2.
Mulcahy, Andrew, et al.. (2024). Comparing Insulin Prices in the United States to Other Countries: Updated Results Using 2022 Data. RAND Corporation eBooks. 11(3). 3–3. 1 indexed citations
3.
Mulcahy, Andrew, et al.. (2024). International Prescription Drug Price Comparisons: Estimates Using 2022 Data. RAND Corporation eBooks. 11(3). 5–5. 12 indexed citations
4.
Mulcahy, Andrew. (2024). Comparing New Prescription Drug Availability and Launch Timing in the United States and Other OECD Countries. RAND Corporation eBooks. 11(3). 4–4. 1 indexed citations
5.
Mulcahy, Andrew. (2022). Projected US savings from biosimilars, 2021-2025. The American Journal of Managed Care. 28(7). 329–335. 29 indexed citations
6.
Baker, Lawrence, et al.. (2021). Estimating the Cost of Industry Investment in Drug Research and Development: A Review of Methods and Results. INQUIRY The Journal of Health Care Organization Provision and Financing. 58. 20 indexed citations
7.
Horvitz‐Lennon, Marcela, et al.. (2021). Significance and Factors Associated with Antipsychotic Polypharmacy Utilization Among Publicly Insured US Adults. Administration and Policy in Mental Health and Mental Health Services Research. 49(1). 59–70. 1 indexed citations
9.
Fingar, Kathryn R., Rosanna M. Coffey, Andrew Mulcahy, Roxanne M Andrews, & Carol Stocks. (2018). Shifts in Medicaid and Uninsured Payer Mix at Safety-Net and Non-Safety-Net Hospitals During the Great Recession. Journal of Healthcare Management. 63(3). 156–172. 1 indexed citations
10.
Wu, Vivian Y., Kathryn R. Fingar, Hui Jiang, et al.. (2018). Early Impact of the Affordable Care Act Coverage Expansion on Safety‐Net Hospital Inpatient Payer Mix and Market Shares. Health Services Research. 53(5). 3617–3639. 2 indexed citations
11.
Kapinos, Kandice A., Shira H. Fischer, Andrew Mulcahy, Oliver Hayden, & Richard Barron. (2018). Medical Costs for Osteoporosis‐Related Fractures in High‐Risk Medicare Beneficiaries. Journal of the American Geriatrics Society. 66(12). 2298–2304. 11 indexed citations
12.
Fischer, Shira H., Kandice A. Kapinos, Andrew Mulcahy, et al.. (2017). Estimating the long-term functional burden of osteoporosis-related fractures. Osteoporosis International. 28(10). 2843–2851. 40 indexed citations
13.
Mulcahy, Andrew. (2016). Evaluating the Impact of the Medicaid Primary Care Payment Bump Using Medical Claims Data. 1 indexed citations
14.
Wynn, Barbara O., et al.. (2016). Implementing a Drug Formulary for California's Workers' Compensation Program. RAND Corporation eBooks. 6(3). 4–4. 3 indexed citations
15.
Mulcahy, Andrew, Zachary Predmore, & Soeren Mattke. (2014). The Cost Savings Potential of Biosimilar Drugs in the United States. RAND Corporation eBooks. 56 indexed citations
16.
Moore, Melinda, et al.. (2014). Health Sector Reform in the Kurdistan Region — Iraq. 1 indexed citations
17.
Hilborne, Lee H., et al.. (2014). Health Sector Reform in the Kurdistan Region - Iraq: Financing Reform, Primary Care, and Patient Safety.. PubMed. 4(3). 2–2. 11 indexed citations
18.
Wynn, Barbara O., et al.. (2013). Implementing a Resource-Based Relative Value Scale Fee Schedule for Physician Services. 1 indexed citations
19.
Chari, Ramya, Peter S. Hussey, Andrew Mulcahy, et al.. (2012). Flattening the Trajectory of Health Care Spending: Promote Population Health. RAND Corporation eBooks.
20.
Mulcahy, Andrew. (2011). Patent policy and entry: Evidence from pharmaceutical patent challenges. PLoS ONE. 19(4). e0301897–e0301897. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026